Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Packaging & Container

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1500649

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1500649

Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029

PUBLISHED:
PAGES: 320 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

The empty capsules market is projected to reach USD 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024, at a CAGR of 6.3% during the forecast period. This market's growth can be attributed to the growth in the pharmaceutical market, the increasing number of clinical trials and R&D activities, and the expansion of over-the-counter medications.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Volume (Units)
SegmentsBy Type, Functionality, Therapeutic Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"The gelatin capsules segment accounted for the largest share by type in 2023."

In 2023, the gelatin segment accounted for the largest share of type in the global empty capsules market. Factors such as availability of gelatin empty capsules in various colors, sizes, and printing options enables pharmaceutical companies to tailor their products to specific market segments, enhancing brand recognition and consumer appeal are expected to drive the segmeng growth.

""The Asia Pacific region is growing in the empty capsules market during the forecast period of 2024-2029."

The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. The expanding pharmaceutical industry, combined with increasing healthcare spending, creates a strong demand for these capsules as crucial components in drug delivery systems. Additionally, the rising prevalence of chronic diseases and infectious illnesses necessitates diverse pharmaceutical formulations, further fueling the need for empty capsules. The growing awareness of preventive healthcare and the popularity of dietary supplements also contribute to market growth. Moreover, the region's robust manufacturing capabilities and cost-effective production methods enhance the accessibility of empty capsules across various pharmaceutical and nutraceutical applications. Additionally, favorable government policies and initiatives supporting healthcare infrastructure development and pharmaceutical innovation reinforce the market's expansion.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side 20%
  • By Designation: Managers - 35%, CXO & Directors - 20%, and Executives - 45%
  • By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • Capsugel (Lonza) (Switzerland)
  • ACG (India)
  • QUALICAPS (Roquette Freres) (France)
  • SUHEUNG (South Korea)
  • Shanxi Guangsheng Capsule Limited (China)
  • CapsCanada (Lyfe Group) (US)
  • HealthCaps India (India)
  • Nectar Lifesciences Ltd. (India)
  • Sunil Healthcare Limited (India)
  • Farmacapsulas (Colombia)
  • NATURAL CAPSULES LIMITED (India)
  • Erawat Pharma Limited (India)
  • Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China)
  • Fortcaps ( Kumar Organic Products Limited) (India)
  • Comed Chemicals Limited (India)
  • Roxlor (US)
  • Medisca Inc. (US)
  • Zhejiang Yuexi Capsule Co. (China)
  • ZHEJIANG HUILI CAPSULES CO., LTD (China)
  • Shaoxing Zhongya Capsule Co., Ltd. (China)
  • Shing Lih Fang Enterprise Co., Ltd. (Taiwan)
  • Chemcaps Limited (India)
  • SNAIL PHARMA INDUSTRY (China)
  • SavoiurCaps (India)
  • Shanxi JC Biological Technology CO. (China)
  • Shaoxing Kangke Capsule Co., Ltd. (China)
  • Lefancaps (Canada)
  • BIO-CAPS INDIA LTD. (India)
  • BioCaps Enterprise (US)
  • Bright Pharma Caps (US)
  • SHREE PHARMA CAPS (India)

Research Coverage:

This research report categorizes the empty capsules market by ((non-gelatin capsules (hydroxypropyl methylcellulose (HPMC) capsules, and pullulan & starch capsules), and gelatin capsules (porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources), and), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), functionality (immediate-release capsules, sustained-release capsules, and delayed-release capsules), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories).

The report provides in-depth information on significant factors influencing the growth of the empty capsules market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches, mergers, and acquisitions within the empty capsules market.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (increasing demand for nutraceuticals and expansion of the Over-the-counter medications), restraints (cultural practices and dietary restrictions, and issues related to the safety and side effects of gelatin capsules), opportunities (expansion of capsule production in emerging countries and development of halal gelatin and vegetarian capsules), and challenges (rising prices and lower availability of raw materials in the gelatin industry and climate issues in the production and storage of empty capsules) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products of the empty capsules market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the empty capsules market
  • Competitive Assessment: Capsugel (Lonza) (Switzerland), ACG (India), QUALICAPS (Roquette Freres) (France), SUHEUNG (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US), HealthCaps India (India), Nectar Lifesciences Ltd. (India), Sunil Healthcare Limited (India), Farmacapsulas (Colombia), NATURAL CAPSULES LIMITED (India), Erawat Pharma Limited (India), Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China), Fortcaps ( Kumar Organic Products Limited) (India), Comed Chemicals Limited (India), Roxlor (US), Medisca Inc. (US), Zhejiang Yuexi Capsule Co. (China), ZHEJIANG HUILI CAPSULES CO., LTD (China), Shaoxing Zhongya Capsule Co., Ltd. (China), Shing Lih Fang Enterprise Co., Ltd. (Taiwan), Chemcaps Limited (India), among others in the market.
Show more
Product Code: PH 2935

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 UNITS CONSIDERED
    • 1.4.1 CURRENCY/VALUE UNIT
    • 1.4.2 VOLUME UNIT
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 EMPTY CAPSULES MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2023)
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
    • FIGURE 5 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VOLUME (2023)
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 TOP-DOWN APPROACH
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS
    • TABLE 2 RISK ASSESSMENT ANALYSIS
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 EMPTY CAPSULES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 10 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 EMPTY CAPSULES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 GEOGRAPHIC SNAPSHOT OF EMPTY CAPSULES MARKET

4 PREMIUM INSIGHTS

  • 4.1 EMPTY CAPSULES MARKET OVERVIEW
    • FIGURE 14 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2023)
    • FIGURE 15 GELATIN CAPSULES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.3 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (2023)
    • FIGURE 16 ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.4 EMPTY CAPSULES MARKET, BY END USER (2023)
    • FIGURE 17 PHARMACEUTICAL INDUSTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.5 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 3 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for nutraceuticals
      • 5.2.1.2 Growing focus on pharmaceutical development and subsequent increase in clinical trials
    • FIGURE 20 TOTAL PRESCRIPTION DRUG SALES, 2014-2028 (USD BILLION)
    • FIGURE 21 NUMBER OF CLINICAL TRIALS REGISTERED, 2001-2023
      • 5.2.1.3 Advancements in capsule delivery technologies
      • 5.2.1.4 Benefits of capsules over other dosage forms
      • 5.2.1.5 Growing preference for self-medication and OTC drugs
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dietary restrictions associated with gelatin consumption
      • 5.2.2.2 Issues related to safety and efficacy
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expansion of capsule production in emerging economies
      • 5.2.3.2 Development of halal gelatin and vegetarian capsules
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Variable prices and low availability of raw materials
      • 5.2.4.2 Challenges associated with storage of empty capsules
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICALS & COSMETICS
    • 5.3.2 GROWING PREFERENCE FOR VEGETARIAN/NON-GELATIN CAPSULES
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN EMPTY CAPSULES MARKET
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 23 EMPTY CAPSULES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 PRICING ANALYSIS
    • TABLE 4 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE (2021-2023)
    • TABLE 5 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2023)
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Advanced quality control systems
      • 5.7.1.2 Automated encapsulation machines
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 3D printing
      • 5.7.2.2 Enteric capsule technologies
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Nanotechnology
      • 5.7.3.2 AI in capsule manufacturing
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 24 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS
  • 5.9 ECOSYSTEM ANALYSIS
    • FIGURE 25 EMPTY CAPSULES MARKET: ECOSYSTEM ANALYSIS
    • 5.9.1 EMPTY CAPSULES MARKET: ROLE OF RAW MATERIAL VENDORS
    • TABLE 6 EMPTY CAPSULES MARKET: ROLE OF RAW MATERIAL VENDORS
    • 5.9.2 EMPTY CAPSULES MARKET: ROLE OF PRODUCT PROVIDERS
    • TABLE 7 EMPTY CAPSULES MARKET: ROLE OF PRODUCT PROVIDERS
    • 5.9.3 EMPTY CAPSULES MARKET: ROLE OF END USERS
    • TABLE 8 EMPTY CAPSULES MARKET: ROLE OF END USERS
    • 5.9.4 EMPTY CAPSULES MARKET: ROLE OF REGULATORY AUTHORITIES
    • TABLE 9 EMPTY CAPSULES MARKET: ROLE OF REGULATORY AUTHORITIES
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 26 EMPTY CAPSULES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • TABLE 10 EMPTY CAPSULES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT METHODOLOGY
    • 5.11.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
    • TABLE 11 PATENTS FILED, 2014-2024
    • 5.11.3 INNOVATION & PATENT APPLICATIONS
    • FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014-2024
    • 5.11.4 TOP APPLICANTS
    • FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024
    • TABLE 12 TOP 20 PATENT OWNERS IN EMPTY CAPSULES, 2014-2024
    • TABLE 13 INDICATIVE LIST OF PATENTS IN EMPTY CAPSULES MARKET, 2023-2024
  • 5.12 KEY CONFERENCES & EVENTS, 2024-2025
    • TABLE 14 EMPTY CAPSULES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024-2025
  • 5.13 TRADE ANALYSIS
    • TABLE 15 IMPORT VALUE FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019-2023 (USD THOUSAND)
    • TABLE 16 EXPORT VALUE FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019-2023 (USD THOUSAND)
    • TABLE 17 IMPORT VOLUME FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019-2023 (TONS)
    • TABLE 18 EXPORT VOLUME FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019-2023 (TONS)
  • 5.14 REGULATORY LANDSCAPE
    • 5.14.1 REGULATORY SCENARIO
    • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EMPTY CAPSULES
    • 5.15.2 BUYING CRITERIA FOR EMPTY CAPSULES
    • FIGURE 30 KEY BUYING CRITERIA FOR EMPTY CAPSULES
    • TABLE 23 BUYING CRITERIA FOR EMPTY CAPSULE PRODUCTS, BY END USER
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 INSIGHTS ON PHARMACEUTICAL GELATIN MARKET

6 EMPTY CAPSULES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 24 EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 25 EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (BILLION UNITS)
  • 6.2 GELATIN CAPSULES
    • TABLE 26 GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 27 GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 28 GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (BILLION UNITS)
    • TABLE 29 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 30 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 32 LATIN AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1 PORCINE GELATIN
      • 6.2.1.1 Porcine gelatin segment to dominate market
    • TABLE 33 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 34 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 35 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 37 LATIN AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2 BOVINE-DERIVED GELATIN
      • 6.2.2.1 Growing demand for stabilizing agents in pharmaceutical formulations to drive market
    • TABLE 38 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 39 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 40 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 42 LATIN AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.3 BONEMEAL GELATIN
      • 6.2.3.1 Ability to be used as substitutes for porcine gelatin to boost demand
    • TABLE 43 BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 44 NORTH AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 45 EUROPE: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 46 ASIA PACIFIC: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 47 LATIN AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4 OTHER GELATIN SOURCES
    • TABLE 48 OTHER GELATIN SOURCES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 49 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 50 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 52 LATIN AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 NON-GELATIN CAPSULES
    • TABLE 53 NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 54 NON-GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 55 NON-GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (BILLION UNITS)
    • TABLE 56 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 57 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 58 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 59 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC) CAPSULES
      • 6.3.1.1 Growing applications in pharmaceutical, nutraceutical, and OTC formulations to drive market
    • TABLE 60 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 61 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 62 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 64 LATIN AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.2 PULLULAN & STARCH CAPSULES
      • 6.3.2.1 High manufacturing cost to restrain market
    • TABLE 65 PULLULAN & STARCH CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 66 NORTH AMERICA: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 69 LATIN AMERICA: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY

  • 7.1 INTRODUCTION
    • TABLE 70 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
  • 7.2 IMMEDIATE-RELEASE CAPSULES
    • 7.2.1 RAPID ABSORPTION AND BROAD APPLICATIONS TO PROPEL MARKET
    • TABLE 71 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 72 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 73 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 75 LATIN AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 SUSTAINED-RELEASE CAPSULES
    • 7.3.1 CONTROLLED DRUG RELEASE FOR CHRONIC DISEASE MANAGEMENT TO DRIVE MARKET
    • TABLE 76 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 77 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 78 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 80 LATIN AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4 DELAYED-RELEASE CAPSULES
    • 7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET
    • TABLE 81 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 82 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 83 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 85 LATIN AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 86 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
  • 8.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS
    • 8.2.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
    • TABLE 87 EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 88 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 89 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 DIETARY SUPPLEMENTS
    • 8.3.1 HIGH UPTAKE OF MULTIVITAMINS TO BOOST DEMAND
    • TABLE 92 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 93 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 94 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 96 LATIN AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.4 ANTACID & ANTIFLATULENT PREPARATIONS
    • 8.4.1 APPLICATIONS IN GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
    • TABLE 97 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 101 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.5 ANTIANEMIC PREPARATIONS
    • 8.5.1 RISING PREVALENCE OF ANEMIA TO SUPPORT MARKET GROWTH
    • TABLE 102 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 103 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 104 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 106 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.6 ANTI-INFLAMMATORY DRUGS
    • 8.6.1 GROWING PREFERENCE FOR NSAIDS AND DMARDS TO PROPEL MARKET
    • TABLE 107 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 108 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 109 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 111 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.7 CARDIOVASCULAR THERAPY DRUGS
    • 8.7.1 INCREASING PREVALENCE OF CVD TO SUPPORT MARKET GROWTH
    • TABLE 112 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 113 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 114 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 116 LATIN AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.8 COUGH & COLD DRUGS
    • 8.8.1 GROWING PREFERENCE FOR OTC FORMULATIONS TO BOOST DEMAND
    • TABLE 117 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 118 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 119 EUROPE: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 121 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.9 OTHER THERAPEUTIC APPLICATIONS
    • TABLE 122 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 123 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 124 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 126 LATIN AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

9 EMPTY CAPSULES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 127 EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2 PHARMACEUTICAL INDUSTRY
    • 9.2.1 INCREASING FOCUS ON DRUG DISCOVERY & DEVELOPMENT ACTIVITIES TO PROPEL MARKET
    • TABLE 128 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 129 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 130 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 132 LATIN AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.3 NUTRACEUTICAL INDUSTRY
    • 9.3.1 GROWING DEMAND FOR DIETARY SUPPLEMENTS TO BOOST DEMAND
    • TABLE 133 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 134 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 135 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 137 LATIN AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.4 COSMETICS INDUSTRY
    • 9.4.1 RISING FOCUS ON HOLISTIC WELLNESS TO SUPPORT MARKET GROWTH
    • TABLE 138 EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 139 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 140 EUROPE: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 142 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.5 RESEARCH LABORATORIES
    • 9.5.1 INCREASING CLINICAL TRIALS TO SUPPORT MARKET GROWTH
    • TABLE 143 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 144 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 145 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 147 LATIN AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)

10 EMPTY CAPSULES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 148 EMPTY CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 149 EMPTY CAPSULES MARKET, BY REGION, 2022-2029 (BILLION UNITS)
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 31 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
    • TABLE 150 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 151 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 152 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 153 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 154 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 155 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 156 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 Rising demand for generic drugs to fuel market
    • TABLE 157 US: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 US: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 159 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 160 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 161 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 162 US: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Growing focus on nutraceutical exports to propel market
    • TABLE 163 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 164 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 165 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 166 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 167 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 168 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 EUROPE: RECESSION IMPACT
    • TABLE 169 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 170 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 171 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 172 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 173 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 174 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 175 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 High demand for capsule-based pharma & nutraceutical formulations to propel market
    • TABLE 176 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 177 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 178 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 179 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 180 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 181 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Low cost of generics to boost demand
    • TABLE 182 UK: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 183 UK: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 184 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 185 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 186 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 187 UK: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 Ban on bovine-based food-grade gelatin to restrain market
    • TABLE 188 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 189 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 190 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 191 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 192 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 193 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 High R&D spending to support market growth
    • TABLE 194 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 195 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 196 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 197 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 198 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 199 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Low production costs to drive market
    • TABLE 200 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 201 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 202 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 203 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 204 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 205 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 206 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 207 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 208 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 209 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 210 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 211 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 32 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
    • TABLE 212 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 217 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 218 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Rising incidence of infectious diseases and increasing market
    • TABLE 219 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 220 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 221 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 222 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 223 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 224 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growth in pharmaceutical industry to boost demand
    • TABLE 225 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 226 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 227 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 228 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 229 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 230 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.4 JAPAN
      • 10.4.4.1 Rising advancements in drug delivery technologies to boost demand
    • TABLE 231 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 232 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 233 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 234 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 235 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 236 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Presence of several pharmaceutical manufacturers to fuel market
    • TABLE 237 SOUTH KOREA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 238 SOUTH KOREA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 239 SOUTH KOREA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 240 SOUTH KOREA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 241 SOUTH KOREA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 242 SOUTH KOREA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 243 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 244 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 245 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 246 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 247 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 248 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 249 LATIN AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 250 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 251 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 252 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 253 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 254 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 255 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.2 BRAZIL
      • 10.5.2.1 High export of generics to support market growth
    • TABLE 256 BRAZIL: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 257 BRAZIL: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 258 BRAZIL: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 259 BRAZIL: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 260 BRAZIL: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 261 BRAZIL: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Favorable healthcare regulations to fuel market
    • TABLE 262 MEXICO: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 263 MEXICO: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 264 MEXICO: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 265 MEXICO: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 266 MEXICO: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 267 MEXICO: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 268 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 269 REST OF LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 270 REST OF LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 271 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 272 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 273 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6 MIDDLE EAST
    • 10.6.1 RISING DEMAND FOR HALAL-CERTIFIED PRODUCTS TO DRIVE MARKET
    • 10.6.2 MIDDLE EAST: RECESSION IMPACT
    • TABLE 274 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 275 MIDDLE EAST: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 276 MIDDLE EAST: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 278 MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 279 MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.7 AFRICA
    • 10.7.1 RISING FOCUS ON API DEVELOPMENT TO SUPPORT MARKET GROWTH
    • 10.7.2 AFRICA: RECESSION IMPACT
    • TABLE 280 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 281 AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 282 AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 283 AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION)
    • TABLE 284 AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 285 AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN EMPTY CAPSULES MARKET
    • TABLE 286 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • 11.3 REVENUE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET, 2021-2023 (USD MILLION)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 34 EMPTY CAPSULES MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
    • TABLE 287 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 35 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
    • FIGURE 36 EMPTY CAPSULES MARKET: COMPANY FOOTPRINT
      • 11.5.5.2 Region footprint
    • TABLE 288 EMPTY CAPSULES MARKET: REGION FOOTPRINT
      • 11.5.5.3 Type footprint
    • TABLE 289 EMPTY CAPSULES MARKET: TYPE FOOTPRINT
      • 11.5.5.4 Functionality footprint
    • TABLE 290 EMPTY CAPSULES MARKET: FUNCTIONALITY FOOTPRINT
      • 11.5.5.5 End-user footprint
    • TABLE 291 EMPTY CAPSULES MARKET: END-USER FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 37 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • TABLE 292 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 293 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • FIGURE 38 EV/EBITDA OF KEY VENDORS
    • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 11.8 BRAND/PRODUCT COMPARISON
    • FIGURE 40 EMPTY CAPSULES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 294 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- MAY 2024
    • 11.9.2 DEALS
    • TABLE 295 EMPTY CAPSULES MARKET: DEALS, JANUARY 2021-MAY 2024
    • 11.9.3 EXPANSIONS
    • TABLE 296 EMPTY CAPSULES MARKET: EXPANSIONS, JANUARY 2021-MAY 2024
    • 11.9.4 OTHER DEVELOPMENTS
    • TABLE 297 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
  • 12.1 KEY PLAYERS
    • 12.1.1 CAPSUGEL (LONZA)
    • TABLE 298 LONZA: COMPANY OVERVIEW
    • FIGURE 41 LONZA: COMPANY SNAPSHOT (2023)
    • TABLE 299 CAPSUGEL (LONZA): PRODUCTS OFFERED
    • TABLE 300 CAPSUGEL (LONZA): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • TABLE 301 CAPSUGEL (LONZA): OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024
    • 12.1.2 ACG
    • TABLE 302 ACG: COMPANY OVERVIEW
    • TABLE 303 ACG: PRODUCTS OFFERED
    • TABLE 304 ACG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • TABLE 305 ACG: DEALS, JANUARY 2021-MAY 2024
    • TABLE 306 ACG: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024
    • 12.1.3 QUALICAPS (ROQUETTE FRERES)
    • TABLE 307 QUALICAPS (ROQUETTE FRERES): COMPANY OVERVIEW
    • TABLE 308 QUALICAPS (ROQUETTE FRERES): PRODUCTS OFFERED
    • TABLE 309 QUALICAPS (ROQUETTE FRERES): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • TABLE 310 QUALICAPS (ROQUETTE FRERES): DEALS, JANUARY 2021-MAY 2024
    • TABLE 311 QUALICAPS (ROQUETTE FRERES): OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024
    • 12.1.4 SUHEUNG
    • TABLE 312 SUHEUNG: COMPANY OVERVIEW
    • FIGURE 42 SUHEUNG: COMPANY SNAPSHOT (2023)
    • TABLE 313 SUHEUNG: PRODUCTS OFFERED
    • TABLE 314 SUHEUNG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • 12.1.5 SHANXI GUANGSHENG CAPSULE LIMITED
    • TABLE 315 SHANXI GUANGSHENG CAPSULE LIMITED: COMPANY OVERVIEW
    • TABLE 316 SHANXI GUANGSHENG CAPSULE LIMITED: PRODUCTS OFFERED
    • TABLE 317 SHANXI GUANGSHENG CAPSULE LIMITED: OTHER DEVELOPMENTS, JANUARY 2021- MAY 2024
    • 12.1.6 CAPSCANADA (LYFE GROUP)
    • TABLE 318 CAPSCANADA (LYFE GROUP): COMPANY OVERVIEW
    • TABLE 319 CAPSCANADA (LYFE GROUP): PRODUCTS OFFERED
    • 12.1.7 HEALTHCAPS INDIA
    • TABLE 320 HEALTHCAPS INDIA: COMPANY OVERVIEW
    • FIGURE 43 HEALTHCAPS INDIA: COMPANY SNAPSHOT (2022)
    • TABLE 321 HEALTHCAPS INDIA: PRODUCTS OFFERED
    • 12.1.8 NECTAR LIFESCIENCES LTD.
    • TABLE 322 NECTAR LIFESCIENCES LTD.: COMPANY OVERVIEW
    • FIGURE 44 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2022)
    • TABLE 323 NECTAR LIFESCIENCES LTD.: PRODUCTS OFFERED
    • 12.1.9 SUNIL HEALTHCARE LIMITED
    • TABLE 324 SUNIL HEALTHCARE LIMITED: COMPANY OVERVIEW
    • FIGURE 45 SUNIL HEALTHCARE LIMITED COMPANY SNAPSHOT (2022)
    • TABLE 325 SUNIL HEALTHCARE LIMITED: PRODUCTS OFFERED
    • 12.1.10 FARMACAPSULAS
    • TABLE 326 FARMACAPSULAS: COMPANY OVERVIEW
    • TABLE 327 FARMACAPSULAS: PRODUCTS OFFERED
    • 12.1.11 NATURAL CAPSULES LIMITED
    • TABLE 328 NATURAL CAPSULES LIMITED: COMPANY OVERVIEW
    • FIGURE 46 NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT (2023)
    • TABLE 329 NATURAL CAPSULES LIMITED: PRODUCTS OFFERED
    • TABLE 330 NATURAL CAPSULES LIMITED: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024
    • 12.1.12 ERAWAT PHARMA LIMITED
    • TABLE 331 ERAWAT PHARMA LIMITED: COMPANY OVERVIEW
    • TABLE 332 ERAWAT PHARMA LIMITED: PRODUCTS OFFERED
    • 12.1.13 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.)
    • TABLE 333 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY OVERVIEW
    • FIGURE 47 BAOTOU DONGBAO BIO-TECH CO., LTD.: COMPANY SNAPSHOT (2022)
    • TABLE 334 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCTS OFFERED
    • TABLE 335 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • 12.1.14 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED)
    • TABLE 336 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY OVERVIEW
    • TABLE 337 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): PRODUCTS OFFERED
    • TABLE 338 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): DEALS, JANUARY 2021-MAY 2024
    • 12.1.15 COMED CHEMICALS LIMITED
    • TABLE 339 COMED CHEMICALS LIMITED: COMPANY OVERVIEW
    • FIGURE 48 COMED CHEMICALS LIMITED: COMPANY SNAPSHOT (2022)
    • TABLE 340 COMED CHEMICALS LIMITED: PRODUCTS OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 SAVIOURCAPS
    • TABLE 341 SAVIOURCAPS: COMPANY OVERVIEW
    • 12.2.2 SHANXI JC BIOLOGICAL TECHNOLOGY CO.
    • TABLE 342 SHANXI JC BIOLOGICAL TECHNOLOGY CO.: COMPANY OVERVIEW
    • 12.2.3 ROXLOR
    • TABLE 343 ROXLOR: COMPANY OVERVIEW
    • 12.2.4 MEDISCA INC.
    • TABLE 344 MEDISCA INC.: COMPANY OVERVIEW
    • 12.2.5 ZHEJIANG YUEXI CAPSULE CO., LTD.
    • TABLE 345 ZHEJIANG YUEXI CAPSULE CO., LTD.: COMPANY OVERVIEW
    • 12.2.6 SHAOXING KANGKE CAPSULE CO., LTD.
    • TABLE 346 SHAOXING KANGKE CAPSULE CO., LTD.: BUSINESS OVERVIEW
    • 12.2.7 ZHEJIANG HUILI CAPSULES CO., LTD.
    • TABLE 347 ZHEJIANG HUILI CAPSULES CO., LTD.: COMPANY OVERVIEW
    • 12.2.8 SHAOXING ZHONGYA CAPSULE CO., LTD.
    • TABLE 348 SHAOXING ZHONGYA CAPSULE CO., LTD.: COMPANY OVERVIEW
    • 12.2.9 SHING LIH FANG ENTERPRISE CO., LTD.
    • TABLE 349 SHING LIH FANG ENTERPRISE CO., LTD.: COMPANY OVERVIEW
    • 12.2.10 LEFANCAPS
    • TABLE 350 LEFANCAPS: COMPANY OVERVIEW
    • 12.2.11 CHEMCAPS LIMITED
    • TABLE 351 CHEMCAPS LIMITED: COMPANY OVERVIEW
    • 12.2.12 BIO-CAPS INDIA LTD.
    • TABLE 352 BIO-CAPS INDIA LTD.: COMPANY OVERVIEW
    • 12.2.13 BIOCAPS ENTERPRISE
    • TABLE 353 BIOCAPS ENTERPRISE: COMPANY OVERVIEW
    • 12.2.14 SNAIL PHARMA INDUSTRY
    • TABLE 354 SNAIL PHARMA INDUSTRY: COMPANY OVERVIEW
    • 12.2.15 BRIGHT PHARMA CAPS
    • TABLE 355 BRIGHT PHARMA CAPS: COMPANY OVERVIEW
    • 12.2.16 SHREE PHARMA CAPS
    • TABLE 356 SHREE PHARMA CAPS: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!